Transplant coronary artery disease in children

Progress in Pediatric Cardiology

Volumn 11, Issue 2, 2000, Pages 137-143

  Pahl, Elfriede ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Children; Coronary disease; Heart transplantation

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PRAVASTATIN; PREDNISONE;

ADULT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; VASCULAR DISEASE;

EID: 0034214028     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(00)00045-X     Document Type: Article

References (32)

1. Uretsky B.F., Murali S., Reddy P.S. et al. Development of coronary artery disease in cardiac transplant recipients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation. 76:1987;827-834.
2. Pahl E., Fricker I.J., Armitage J. et al. Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-term survival. J Pediatr. 2:1990;177-183.
3. Pahl E., Zales V.R., Fricker F.J. et al. Posttransplant coronary artery disease in children. A multicenter national survey. Circulation. 90(part 2):1994;II56-II60.
4. Costanzo M., Naftel D.C., Pritzker M.R. et al. Heart transplant coronary artery disease detected by coronary angiography: a multi-institutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant. 17(8):1998;744-753.
5. Hammond E.H., Yowell R.L., Price G.D. et al. Vascular rejection and its relationship to allograft coronary artery disease. J Heart Lung Transplant. 11:1992;S111-S119.
6. Billingham M.E. Histopathology of graft coronary disease. J Heart Lung Transplant. 119(3):1990;538-544.
7. Shaddy R.E., Hammond E.H., Yowell R.L. Immunohistochemical analysis of platelet-derived growth factor and basic fibroblast growth factor in cardiac biopsy and autopsy specimens of heart transplant patients. Am J Cardiol. 77(14):1996;1210-1215.
8. Ventura H.O., Mehra M.R., Smart F.W., Stapleton D.D. Cardiac allograft vasculopathy: current concepts. Am Heart J. 129(4):1995;791-799.
9. Russel M.E. Macrophages and transplant arteriosclerosis. J Heart Lung Transplant. 14(6,2):1995;S111-S115.
10. Miller L, editor. Proceedings of allograft coronary disease: a basic science and clinical review. Proceedings of symposium. J Heart Lung Transplant 1995;14(6,2):S109-S110.
11. Ventura H.O., Kirklin J., Eisen H. et al. The combined impact of pretransplant risk factors frequency and rejection and severity on the prevalence of post-transplant coronary vasculopathy (abstract). J Heart Lung Transplant. 16:1997;66.
12. Olivari M.T., Homans D.C., Wilson R.F., Kubo S.I.I., Ring W.S. Coronary artery disease in cardiac transplant patients receiving triple drug immunosuppressive therapy. Circulation. 5 Pt 2(III):1989;111-115.
13. McDonald K., Rector T.S., Braunlin E.A., Kubo S.H., Olivari M.T. Association of coronary artery disease in transplant recipients with cytomegalovirus infection. Am J Cardiol. 64:1989;359-362.
14. Johnson M.R. Transplant coronary disease: nonimmunologic risk factors. J Heart Lung Transplant. 11:1992;S124-S132.
15. Frazier EA, Naftel DC, Canter CE, Boucek MM, Kirklin JK, Morrow WR. Death after heart transplantation in children: who dies and why (abstract). J Heart Lung Transplant 1999;18(1):69.
16. Smart F.W., Ballantyne C.M., Cocanougher B. et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol. 67:1991;243-247.
17. Spes C.H., Mudra H., Schnaack S.D. et al. Dobutamine stress echocardiography for noninvasive diagnosis of cardiac allograft vasculopathy: a comparison with angiography and intravascular ultrasound. Am J Cardiol. 78(2):1996;168-174.
18. Pahl E, Crawford SE, Swenson JM et al. Dobutamine stress echocardiography: Experience in pediatric heart transplant recipients. J Heart Lung Transplant 1999 (in press).
19. Larsen R., Applegate P.M., Dyar D.A. et al. Dobutamine stress echocardiography for assessing coronary artery disease after transplantation in children. J Am Coll Cardiol. 32:1998;515-520.
20. St. Goar F.G., Pinto F.J., Alderman E.L. et al. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of angiographically silent intimal thickening. Circulation. 85:1992;979-987.
21. Rickenbacher P.R., Kemna M.S., Pinto F.J. et al. Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary ultrasound study of immunologic and metabolic risk factors. Transplantation. 61(1):1996;46-53.
22. Dent C.L., Canter C.E., Hirsch R., Sekarski R.J., Balzer D.T. Risk factors for graft vasculopathy in pediatric heart transplant recipients (abstract). Circulation. 98(17):1998;I167.
23. Halle III A.A., DiSciascio G., Massin E.K. et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol. 26(1):1995;120-128.
24. Wong P.M., Piamsomboon C., Mathur A. et al. Efficacy of coronary stenting in the management of cardiac allograft vasculopathy. Am J Cardiol. 82:1998;239-241.
25. Michler R.E., Edwards N.M., Hsu D. et al. Pediatric retransplantation. J Heart Lung Transplant. 12:1993;S319-S327.
26. Razzouk A.J., Chinnock R.E., Dearani J.A., Gundry S.R., Bailey L.L. Cardiac retransplantation for graft vasculopathy in children: should we continue to do it? Arch Surg. 133(8):1998;881-885.
27. Mehra M.R., Ventura H.O., Smart F.W., Stapleton D.D. Impact of converting enzyme inhibitors and calcium entry blockers on cardiac allograft vasculopathy: from bench to bedside. J Heart Lung Transplant. 14(6,2):1995;S246-S249.
28. Schroeder J.S., Gao S.Z., Alderman E.L. et al. A preliminary study of dilitiazem in the prevention of coronary artery disease in heart transplant recipients. New Engl J Med. 328:1993;164-170.
29. Takami H., Backer C.L., Crawford S.E., Pahl E., Mavroudis C. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease. J Heart Lung Transplant. 15(1 Pt1):1996;67-77.
30. Kobayashi J., Crawford S.E., Backer C.L. et al. Captopril reduces graft coronary disease in a rat heterotopic transplant model. Circulation. 88(suppl. II):1993;286-290.
31. Kobashigawa J.A., Katznelson S., Laks H. et al. Effect of pravastatin on outcomes after cardiac transplantation. New Engl J Med. 10:1995;621-627.
32. Pahl E, Crawford SE, Rodgers S et al. High incidence of hypercholesterolemia after pediatric heart transplantation (abstract). Transplantation 1999;66(9) April.